Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × cannabichromene × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cyclophosphamide 2766 Cisplatin 2748 Carboplatin 2552 Radiotherapy 2355 Paclitaxel 2335 Gemcitabine 2204 pembrolizumab 2028 Docetaxel 1912 Bevacizumab 1856 Fluorouracil 1610 Capecitabine 1576 Oxaliplatin 1496 Dexamethasone 1380 Nivolumab 1313 Doxorubicin 1292 Rituximab 1279 Etoposide 1180 Magnetic Resonance Spectroscopy 1101 Irinotecan 1086 Leucovorin 1069 Cytarabine 995 Drug Therapy 923 fludarabine 918 Pemetrexed 911 Vincristine 824 Prednisone 814 Lenalidomide 808 Cetuximab 797 Specimen Handling 795 Filgrastim 790

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06533657 2026-03-12

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Active not recruiting

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡